Collate vs not collate3/2/2023 The modified intention-to-treat population comprised 844 hepatitis B e antigen (HBeAg)-positive patients (540 completed 3 years’ follow-up), and 872 HBeAg-negative patients (614 completed 3 years’ follow-up). This does not alter our adherence to PLOS ONE policies on sharing data and materials. All authors disclose medical writing support from F. Heiner Wedemeyer: Grant: Abbott, AbbVie, BMS, Gilead, Merck, Novartis, Roche, Roche Diagnostics, Siemens Consultant: Abbott, AbbVie, BMS, Boehringer Ingelheim, Gilead, JJ/Janssen-Cilag, Merck/Schering-Plough, Novartis, Roche, Roche Diagnostics, Siemens, Transgene, ViiV Speaker: Abbott, AbbVie, BMS, Boehringer Ingelheim, Gilead, JJ/Janssen- Cilag, Merck/Schering-Plough, Novartis, Roche, Roche Diagnostics, Siemens, Transgene, ViiV. Pietro Lampertico: Advisory board/speaker bureau: AbbVie, Alnylam, Arrowhead, BMS, Gilead, GSK, Janssen, Merck Sharp & Dohme, Roche. Georgios Bakalos, Loredana Regep, Ulrich Alshuth: Employment: F Hoffmann-La Roche Ltd (Roche s.r.o, Roche Pharma AG). Diethelm Messinger: Employment: Prometris GmbH (provide statistical support for Roche). Georgios Papatheodoridis: Advisory Committees/Review Panels: AbbVie, Boehringer Ingelheim, BMS, Gilead, GSK, Ipsen, Janssen, MSD, Novartis, Roche, Spring Bank Grant/Research Support: AbbVie, BMS, Gilead, Janssen, Roche Speaking and Teaching: AbbVie, BMS, Gilead, GSK, Janssen, MSD, Novartis, Roche Data Safety Management Board: Gilead. Foster: Speaker/consultancy: AbbVie, BMS, Merck, Gilead, Janssen, Tekmira, Alnylam, Roche. Denis Ouzan: Grant and speaker/expert: AbbVie, Gilead, MSD. Data Safety Management Board: Janssen-Cilag. Tarik Asselah: Consultant and Clinical Investigator/Speaker: Roche, AbbVie, BMS, Gilead, Janssen, MSD Markus Cornberg: Advisory Committees/Review Panels: AbbVie, Biogen, BMS, Gilead, Janssen-Cilag, MSD, Roche, Spring Bank Speaking/Teaching: AbbVie, BMS, Falk, Gilead, Janssen-Cilag, MSD, Roche. Jörg Petersen: Grant/Research: BMS, Novartis, Roche Consultant/Advisor: Abbott, AbbVie, BMS, Boehringer Ingelheim, Gilead, GSK, Kedrion, Janssen, MSD, Novartis, Roche Speaker: Abbott, BMS, Boehringer Ingelheim, Gilead, Kedrion, Janssen, Merck, MSD, Novartis, Roche. Teerha Piratvisuth: Grant: Roche, MSD, Bayer Sponsored Lectures: BMS, Roche, MSD, Novartis, GSK Advisory Board: Roche, MSD, BMS. Robert Flisiak: Speaker/advisor: AbbVie, BMS, Gilead, Janssen, MSD, Novartis, Roche. Seung Woon Paik: Research support: BMS, Gilead, GSK, Roche. Qing Xie: Speaker/advisor: AbbVie, BMS, Gilead, Janssen, MSD, Novartis, Roche. Patrick Marcellin: Grant: Abbvie, Assembly Biosciences, Eiger, Genfit Gilead, Intercept, MSD, Investigator: Eiger, Gilead Speaker/expert: Gilead, Hebabiz, MSD, Mylan. The following authors have competing interests to declare. Foster, Data curation, Formal analysis, Writing – review & editing, 9 Georgios Papatheodoridis, Data curation, Formal analysis, Writing – review & editing, 10 Diethelm Messinger, Conceptualization, Formal analysis, Writing – review & editing, 11 Loredana Regep, Formal analysis, Writing – review & editing, 12 Georgios Bakalos, Conceptualization, Formal analysis, Writing – review & editing, 13 Ulrich Alshuth, Conceptualization, Formal analysis, Writing – review & editing, 14 Pietro Lampertico, Data curation, Formal analysis, Writing – review & editing, 15 and Heiner Wedemeyer, Conceptualization, Data curation, Formal analysis 7, ¤ *Ĭompeting Interests: This study was funded by F Hoffmann-La Roche Ltd. Patrick Marcellin, Conceptualization, Data curation, Formal analysis, Writing – original draft, Writing – review & editing, 1 Qing Xie, Data curation, Formal analysis, Writing – review & editing, 2 Seung Woon Paik, Data curation, Writing – review & editing, 3 Robert Flisiak, Data curation, Formal analysis, Writing – review & editing, 4 Teerha Piratvisuth, Conceptualization, Data curation, Formal analysis, Writing – review & editing, 5 Jörg Petersen, Data curation, Formal analysis, Writing – review & editing, 6 Tarik Asselah, Data curation, Formal analysis, Writing – review & editing, 1 Markus Cornberg, Data curation, Formal analysis, Writing – review & editing, 7 Denis Ouzan, Data curation, Formal analysis, Writing – review & editing, 8 Graham R.
0 Comments
Leave a Reply.AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |